Long-term outcomes of penetrating keratoplasty for corneal complications of herpes zoster ophthalmicus

Background/Aim To review the long-term outcomes of penetrating keratoplasty (PKP) for corneal complications of herpes zoster ophthalmicus (HZO). Methods We reviewed the medical records of 53 eyes of 53 patients who underwent PKP due to corneal complications of HZO at the Kellogg Eye Center. Results The mean age of patients at the time of PKP was 68.0±16.4 years, with a follow-up of 4.0±3.8 years and quiescent period of 6.5±5.3 years from active HZO to PKP. Preoperatively, 25 (47.2%) eyes were completely anaesthetic, while 16 (30.2%) had deep corneal neovascularisation in four quadrants. Comorbid ocular disease, including cataract, glaucoma and macular disease, was present in 25 (47.2%) eyes. Twenty patients (37.8%) received acyclovir for the entire postoperative period. There were no recurrences of zoster keratitis in any eye. The most common complications were difficulty healing the ocular surface (12/53, 22.6%) and glaucoma (14/53, 26.4%). Thirty per cent of the eyes required one or more additional postoperative procedures, most commonly tarsorrhaphy (10/53, 18.9%) and amniotic membrane graft (6/53, 11.3%). At 1, 2–4 and ≥5 years, 94%, 82% and 70% grafts remained clear, respectively. Visual acuity improved at 1 year postoperatively (p<0.0001), but this improvement was not sustained. There was no significant benefit of long-term acyclovir on visual acuity (p=0.2132) or graft survival (p=0.241). Conclusions Even in eyes with significant preoperative risk factors, PKP for the corneal complications of HZO can achieve favourable tectonic and visual results. Although most grafts remained clear, long-term visual potential may be limited by comorbid ocular diseases. Prophylactic postoperative oral acyclovir did not improve outcomes.

[1]  J. Forrester,et al.  High-risk corneal allografts: A therapeutic challenge. , 2016, World journal of transplantation.

[2]  C. Rapuano,et al.  Long-term Results of Keratoplasty in Patients With Herpes Zoster Ophthalmicus , 2013, Cornea.

[3]  B. Yawn,et al.  Herpes zoster eye complications: rates and trends. , 2013, Mayo Clinic proceedings.

[4]  L. Smeeth,et al.  Herpes Zoster Vaccine Effectiveness against Incident Herpes Zoster and Post-herpetic Neuralgia in an Older US Population: A Cohort Study , 2013, PLoS medicine.

[5]  K. Schmader,et al.  Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  S. Tyring,et al.  Family history and herpes zoster risk in the era of shingles vaccination. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[7]  E. Cohen,et al.  Herpes zoster ophthalmicus: comparison of disease in patients 60 years and older versus younger than 60 years. , 2011, Ophthalmology.

[8]  M. Yuzawa,et al.  Postoperative risk factors influencing corneal graft survival in the Singapore corneal transplant study. , 2011, American journal of ophthalmology.

[9]  S. Cook,et al.  Antiviral treatment following penetrating keratoplasty for herpetic keratitis , 2011, Eye.

[10]  Claus Cursiefen,et al.  Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty: an evidence-based meta-analysis. , 2010, Ophthalmology.

[11]  M. Dana,et al.  Corneal Graft Rejection , 2009, International ophthalmology clinics.

[12]  Ismael R Ortega-Sanchez,et al.  Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2008, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[13]  Y. Chan,et al.  Penetrating keratoplasty in Asian eyes: the Singapore Corneal Transplant Study. , 2008, Ophthalmology.

[14]  T. Liesegang Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity. , 2008, Ophthalmology.

[15]  P. Peduzzi,et al.  A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. , 2005, The New England journal of medicine.

[16]  T. Liesegang Herpes zoster virus infection , 2004, Current opinion in ophthalmology.

[17]  S. Daya,et al.  Penetrating keratoplasty: indications over a 10 year period , 2004, British Journal of Ophthalmology.

[18]  P. Doornenbal,et al.  Effect of oral acyclovir after penetrating keratoplasty for herpetic keratitis: a placebo-controlled multicenter trial. , 2003, Ophthalmology.

[19]  J. Hill High risk corneal grafting , 2002, The British journal of ophthalmology.

[20]  N. Waheed,et al.  Visual outcome in herpes simplex virus and varicella zoster virus uveitis: a clinical evaluation and comparison. , 2002, Ophthalmology.

[21]  Mohammed Anwar,et al.  Big‐bubble technique to bare Descemet's membrane in anterior lamellar keratoplasty , 2002, Journal of cataract and refractive surgery.

[22]  E. Cohen,et al.  Penetrating Keratoplasty for Varicella-Zoster Virus Keratopathy , 2000, Cornea.

[23]  E. Cohen,et al.  Oral acyclovir after penetrating keratoplasty for herpes simplex keratitis. , 1999, Archives of ophthalmology.

[24]  D. Seamark,et al.  Validation of Current Practice and a near Patient Testing Method for Oral-Anticoagulant Control in General Practice , 1997, Journal of the Royal Society of Medicine.

[25]  J. Reed,et al.  Penetrating keratoplasty for herpes zoster keratopathy. , 1989, American journal of ophthalmology.

[26]  A. Sugar,et al.  Penetrating keratoplasty for corneal scarring due to herpes zoster ophthalmicus. , 1989, The British journal of ophthalmology.

[27]  R. Marsh,et al.  Ocular surgery in ophthalmic Zoster , 1989, Eye.

[28]  D. Coster,et al.  Prognosis and management of corneal transplantation for herpetic keratitis. , 1980, Archives of ophthalmology.

[29]  F. M. Vincent,et al.  Herpes zoster ophthalmicus. , 1979, Archives of neurology.